Improving Multivitamin Supplementation to Pregnant Women

PHASE4CompletedINTERVENTIONAL
Enrollment

1,370

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

January 31, 2008

Conditions
PregnancyMorning SicknessNauseaVomitingHyperemesis Gravidarum
Interventions
DRUG

Pregvit®

Women were randomized to one of two groups. An information package was mailed to each woman, instructing her to commence supplementation with her assigned prenatal multivitamin, according to the product's standard dosing -twice daily for '35 mg' group

DRUG

Orifer F®

Women were randomized to one of two groups. An information package was mailed to each woman, instructing her to commence supplementation with her assigned prenatal multivitamin, according to the product's standard dosing-once daily for '60 mg' group

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duchesnay Inc.

INDUSTRY

lead

The Hospital for Sick Children

OTHER

NCT02300155 - Improving Multivitamin Supplementation to Pregnant Women | Biotech Hunter | Biotech Hunter